by bmi_wpadmin | Sep 23, 2024 | BayMedica, Cannabinoids, CBC, Tetrahydrocannabivarin (THCV)
It is encouraging when ethical decisions also make financial sense. In the cannabis industry, utilizing sustainable bioidentical ingredients derived from the cannabis plant enables us to accomplish both goals. What does a more sustainable industry look like with minor...
by Diego Morales | Sep 23, 2024 | Tetrahydrocannabivarin (THCV)
THCV (tetrahydrocannabivarin), a cannabinoid distinct from THC, is gaining attention for its non-intoxicating focus and appetite-suppressant properties. This article examines THCV’s effects, therapeutic potential, legal considerations, and usage tips, offering a...
by bmi_wpadmin | Sep 23, 2024 | BayMedica, Cannabinoids, Tetrahydrocannabivarin (THCV)
With the increasing demand for health and wellness products that tap into the natural benefits of cannabinoids, non-intoxicating THCV (Tetrahydrocannabivarin) is quickly becoming a standout ingredient for innovative CPG product developers. From metabolic health to...
by bmi_wpadmin | Sep 23, 2024 | BayMedica, Cannabidivarin (CBDV), Cannabinoids
Cannabidivarin, also known as CBDV, is a rare non-intoxicating cannabinoid first isolated in 1969. CBDV may share a similar name to its well-known cousin, cannabidiol, or CBD, but unlike CBD, CBDV is a minor cannabinoid and has demonstrated unique physiological...
by bmi_wpadmin | Sep 23, 2024 | BayMedica, Partners, Product Actualization
A Guide for CPG Brands Leveraging Minor Cannabinoids As the demand for cannabinoid-infused beverages continues to surge, CPG brands and product developers have a unique opportunity to enter this growing market with innovative, compliant, and consumer-focused products....
Recent Comments